Per Ola Kimblad
1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Transapical versus transfemoral aortic valve implantation: a comparison of survival and safety.
(
- Contribution to journal › Article
- 2010
-
Mark
Characterization of the Calcitonin Gene-Related Peptide Receptor Antagonist Telcagepant (MK-0974) in Human Isolated Coronary Arteries
(
- Contribution to journal › Article
- 2009
-
Mark
The prevalence of moderate mitral regurgitation in patients undergoing CABG
(
- Contribution to journal › Article
-
Mark
Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease
(
- Contribution to journal › Article
-
Mark
Moderate mitral regurgitation in patients undergoing CABG - the MoMIC trial
(
- Contribution to journal › Article
- 2006
-
Mark
Percutaneous transvenous mitral annuloplasty - Initial human experience with device implantation in the coronary sinus
(
- Contribution to journal › Article
-
Mark
Successful percutaneous treatment of ischemic mitral regurgitation in sheep.
(
- Contribution to journal › Article
- 2005
-
Mark
Percutaneous transvenous mitral annuloplasty (PTMA) with the Viking device reduces pacing-induced mitral regurgitation.
(
- Contribution to journal › Article
- 2002
-
Mark
Patient reactions to cancelled or postponed heart operations.
(
- Contribution to journal › Article
- 1996
-
Mark
Inhaled nitric oxide reveals and attenuates endothelial dysfunction after lung transplantation
(
- Contribution to journal › Article